STOCK TITAN

Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Quantum-Si to hold webinar on their novel next-generation protein sequencing platform
Positive
  • Quantum-Si's PlatinumTM technology allows for single-molecule protein sequencing
  • Webinar will discuss how PlatinumTM can complement immunoassays and other proteomic workflows
  • Protein sequencing provides deeper insights into proteins and can help in developing new therapeutics
Negative
  • None.

Company to hold webinar with Select Science on Friday, October 6, 2023 at 11 a.m. ET

Quantum-Si Incorporated (Nasdaq: QSI):

WHAT: The protein sequencing company, Quantum-Si, will discuss their novel next-generation protein sequencing platform, PlatinumTM and how it can complement immunoassays and other proteomic workflows by providing deeper insights into proteins. The session will also be joined by Professor of Chemical and Biological Engineering at the Northwestern University, Dr. Danielle Tullman-Ercek. Dr. Tullman-Ercek will illustrate how protein identification on Platinum was utilized in her research to provide additional information about proteins typically studied via conventional western blot and mass spectrometry techniques. She will demonstrate how next-generation protein sequencing provides additional information about proteins, comparing results from conventional techniques to those obtained from next-generation protein sequencing.

WHY: About nine out of 10 drugs target proteins in some capacity, but currently over 85% of the proteome is undrugged. Technologies like Quantum-Si’s Platinum will open this bottleneck on researching the proteome and developing new therapeutics. Quantum-Si’s benchtop device is the only technology available currently that allows for single-molecule protein sequencing.

WHO: Quantum-Si and Northwestern University will bring together researchers with expertise in fields including molecular biology, biochemistry, and genetics who have interest in expanding into proteomics. The webinar will be moderated by:

  • Katherine Johnson, Senior Director, Product, Quantum-Si
  • Dr. Danielle Tullman-Ercek, Professor of Chemical and Biological Engineering, Northwestern University

WHEN: “Next-generation protein sequencing platform: Advances in protein identification & characterization” will be held Friday, October 6, 2023, at 11:00 a.m. ET / 8:00 a.m. PT.

WHERE: Wherever you are – home office, study, etc. Reserve your spot today here: https://www.selectscience.net/register.aspx?itemID=2089&itemTypeID=54

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com.

Investor Relations

Jeff Keyes

ir@quantum-si.com



Media

Michael Sullivan

media@quantum-si.com

Source: Quantum-Si Incorporated

FAQ

What is the topic of the webinar?

The webinar will discuss Quantum-Si's novel next-generation protein sequencing platform, PlatinumTM.

Who will be joining the session?

Dr. Danielle Tullman-Ercek, Professor of Chemical and Biological Engineering at Northwestern University, will be joining the session.

Why is protein sequencing important?

Protein sequencing provides deeper insights into proteins and can help in developing new therapeutics.

What is unique about Quantum-Si's technology?

Quantum-Si's PlatinumTM technology allows for single-molecule protein sequencing.

Where can I reserve a spot for the webinar?

You can reserve your spot for the webinar at the following link: https://www.selectscience.net/register.aspx?itemID=2089&itemTypeID=54

Quantum-Si Incorporated

NASDAQ:QSI

QSI Rankings

QSI Latest News

QSI Stock Data

172.68M
97.95M
19.85%
36.12%
4.15%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States of America
BRANFORD